01.05.14
European regulators have approved Biotronik SE & Co. KG's PK Papyrus covered coronary stent system for the treatment of acute coronary artery perforation.
PK Papyrus has 58 percent greater flexibility than Abbott's Jostent Graftmaster due to its innovative "electrospun" membrane, the company claims in a news release. The enhanced "electrospinning" technology allows for a proprietary single-layer covered stent design rather than the traditional "sandwich technique" used on comparable stents on the market. The single-layer covered stent design, with its 90μm polyurethane membrane, further enables a 24 percent lower crossing profile in comparison to Abbott's Jostent Graftmaster, combining high flexibility and a low crossing profile for improved deliverability while sealing vessel defects in acute situations, Biotronik executives note.
Severe acute perforation is a rare but catastrophic event that can be fatal. One potential treatment is to exclude the defect by deploying a covered stent over the perforation. Many current covered stent designs require large 'French size' (F) guide catheters. Switching guide cathethers can cost the physician valuable time, delaying treatments, Biotronik contends. PK Papyrus is 5 F- and 6 F- compatible, thereby eliminating the need to switch access catheters during these emergency situations.
"In acute situations when there is a vessel perforation, I need a stent that is highly effective and has optimum deliverability," said
Prof. Georg Nickenig, University Hospital Bonn. "With PK Papyrus, I am confident that if such a situation arises, I have a stent that is straight-forward to introduce into the artery with a flexibility that means simplified placement."
While PK Papyrus is based on the same Orsiro/PRO-Kinetic Energy stent platform, the wide size range (diameter 2.5-5 mm, length 15-26 mm) enables a broad range of vessels to be treated.
"PK Papyrus is a testament to the engineering at Biotronik," said Dr. Alexander Uhl, vice president of marketing, Vascular Intervention, at BIOTRONIK. "The application of this electrospinning technology to the Biotronik Orsiro/PRO-Kinetic Energy stent platform has allowed us to introduce a product to the market that will enable physicians to treat patients in emergency situations quickly and safely."
Biotronik is based in Berlin, Germany, and has a global workforce of more than 5,600 employees. Its U.S. headquarters is located in Lake Oswego, Ore.
Biotronik is headquartered in Berlin, Germany, and has a global workforce of more than 5,600 employees. U.S. headquarters are in Lake Oswego, Ore. - See more at: http://www.mpo-mag.com/contents/view_breaking-news/2013-10-02/biotronik-rolls-out-new-line-of-defibrillators/#sthash.nMPffdhR.dpuf
PK Papyrus has 58 percent greater flexibility than Abbott's Jostent Graftmaster due to its innovative "electrospun" membrane, the company claims in a news release. The enhanced "electrospinning" technology allows for a proprietary single-layer covered stent design rather than the traditional "sandwich technique" used on comparable stents on the market. The single-layer covered stent design, with its 90μm polyurethane membrane, further enables a 24 percent lower crossing profile in comparison to Abbott's Jostent Graftmaster, combining high flexibility and a low crossing profile for improved deliverability while sealing vessel defects in acute situations, Biotronik executives note.
Severe acute perforation is a rare but catastrophic event that can be fatal. One potential treatment is to exclude the defect by deploying a covered stent over the perforation. Many current covered stent designs require large 'French size' (F) guide catheters. Switching guide cathethers can cost the physician valuable time, delaying treatments, Biotronik contends. PK Papyrus is 5 F- and 6 F- compatible, thereby eliminating the need to switch access catheters during these emergency situations.
"In acute situations when there is a vessel perforation, I need a stent that is highly effective and has optimum deliverability," said
Prof. Georg Nickenig, University Hospital Bonn. "With PK Papyrus, I am confident that if such a situation arises, I have a stent that is straight-forward to introduce into the artery with a flexibility that means simplified placement."
While PK Papyrus is based on the same Orsiro/PRO-Kinetic Energy stent platform, the wide size range (diameter 2.5-5 mm, length 15-26 mm) enables a broad range of vessels to be treated.
"PK Papyrus is a testament to the engineering at Biotronik," said Dr. Alexander Uhl, vice president of marketing, Vascular Intervention, at BIOTRONIK. "The application of this electrospinning technology to the Biotronik Orsiro/PRO-Kinetic Energy stent platform has allowed us to introduce a product to the market that will enable physicians to treat patients in emergency situations quickly and safely."
Biotronik is based in Berlin, Germany, and has a global workforce of more than 5,600 employees. Its U.S. headquarters is located in Lake Oswego, Ore.
Biotronik is headquartered in Berlin, Germany, and has a global workforce of more than 5,600 employees. U.S. headquarters are in Lake Oswego, Ore. - See more at: http://www.mpo-mag.com/contents/view_breaking-news/2013-10-02/biotronik-rolls-out-new-line-of-defibrillators/#sthash.nMPffdhR.dpuf